Log in to save to my catalogue

Dehydroabietic Acid Microencapsulation Potential as Biofilm-Mediated Infections Treatment

Dehydroabietic Acid Microencapsulation Potential as Biofilm-Mediated Infections Treatment

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a6fdfd3260e74d85abd7e1d737a14a4a

Dehydroabietic Acid Microencapsulation Potential as Biofilm-Mediated Infections Treatment

About this item

Full title

Dehydroabietic Acid Microencapsulation Potential as Biofilm-Mediated Infections Treatment

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceutics, 2021-06, Vol.13 (6), p.825

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

The antimicrobial activity of dehydroabietic acid (DHA) for its use as an antibiofilm agent was tested in this work. DHA was assayed against a collection of Gram-positive, Gram-negative sensitive and resistant bacteria and yeasts through the minimum inhibitory concentration (MIC), MIC with Bioburden challenge, minimum bactericidal concentration (MB...

Alternative Titles

Full title

Dehydroabietic Acid Microencapsulation Potential as Biofilm-Mediated Infections Treatment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a6fdfd3260e74d85abd7e1d737a14a4a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a6fdfd3260e74d85abd7e1d737a14a4a

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics13060825

How to access this item